News Articles Tagged: CAS 1030825-20-7

Ensuring API Quality: The Criticality of 2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene in Canagliflozin Manufacturing

This article discusses the importance of high-purity intermediates, focusing on 2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene (CAS 1030825-20-7) and its role in manufacturing the quality-assured diabetes medication Canagliflozin.

Innovations in Chemical Synthesis: The Journey of 2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene to Canagliflozin

Explore the chemical synthesis journey of 2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene (CAS 1030825-20-7) and its critical role in the manufacturing of the diabetes drug Canagliflozin.

The Significance of Thiophene Derivatives in Pharmaceutical Synthesis: A Case Study of CAS 1030825-20-7

Examines the importance of thiophene-based compounds, such as 2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene (CAS 1030825-20-7), in the development of pharmaceuticals like Canagliflozin.

The Significance of CAS 1030825-20-7 in Canagliflozin Synthesis

Ningbo Inno Pharmchem Co., Ltd. highlights the importance of Canagliflozin intermediate with CAS 1030825-20-7 and its role in organic synthesis.